[ad_1]
Bragar Eagel & Squire, PC, a nationally recognized stockholder rights law firm, is investigating potential claims against Stryker Corporation (“Stryker” or the “Company”) (NYSE:SYK) on behalf of Stryker stockholders. Our investigation concerns whether Stryker has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
Stryker is a medical technology company that operates through two segments: MedSurg and Neurotechnology and Orthopedics and Spine.
On April 6, 2022, Spruce Point Capital Management (Spruce Point) published a report alleging that Stryker has failed …
Full story available on Benzinga.com
[ad_2]
Source link
